News | July 05, 2024
Cardiological Society of India releases first Indian guidelines for dyslipidemia management
Dyslipidemia is a critical risk factor for cardiovascular diseases
Dyslipidemia is a critical risk factor for cardiovascular diseases
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
The integration of SAP S/4HANA Cloud will equip Cupid Limited with a comprehensive suite of integrated applications,
Ibara will drive AI-powered clinical research innovation
Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Aster CMI Hospital has successfully implemented several key digital health initiatives contributing to this accreditation
First immunotherapy regimen before and after surgery to extend survival in bladder cancer
GL0034 administered once-weekly confirmed clinically meaningful weight loss and improved glucometabolic parameters over a 4-week treatment period in individuals with obesity
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
Subscribe To Our Newsletter & Stay Updated
